SCHEMBL4872919

SCHEMBL4872919

Cc1ccc(-n2nccc2CN)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.45
ALDH1A1 P00352 5/20 0.45
ATM Q13315 1/20 0.45
NR3C2 P08235 1/20 0.42
RAB9A P51151 5/20 0.39
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 4/20 0.39
NPC1 O15118 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 3/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TP53 P04637 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
XDH P47989 1/20 0.38
HTT P42858 2/20 0.38
XBP1 P17861 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732531 0.80 ALDH1A1 (0.42) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL17910800 0.80 MAPT (0.49) MAPTALDH1A1NR3C2RAB9ACYP2C9
SCHEMBL2956789 0.79 KDM5A (0.47) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL1491115 0.76 POLB (0.64) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL23130273 0.75 CYP2C9 (0.49) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL17086629 0.74 MAPT (0.54) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL19443416 0.72 ALDH1A1 (0.44) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL20663325 0.72 ALDH1A1 (0.44) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL23401516 0.72 ALDH1A1 (0.44) MAPTALDH1A1ATMNR3C2RAB9A
SCHEMBL15554655 0.72 ALDH1A1 (0.44) MAPTALDH1A1ATMNR3C2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250268248-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2025-08-28 US disclosed
EP-4510831-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2025-02-26 EP disclosed
WO-2023202969-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2023-10-26 WO disclosed
US-7399577-B2 Halogenated oxime derivatives and the use thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-07-15 US disclosed
US-20060246377-A1 Halogenated oxime derivatives and the use thereof as latent acids BASF SE (DE) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268248-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME COASY, HMGCR, CYP51A1 MAPT 1652/4885ALDH1A1 2806/4885ATM 4769/4885
US-20060246377-A1 Halogenated oxime derivatives and the use thereof as latent acids AHR, ARSA, SULT1A1 MAPT 4298/4885ALDH1A1 38/4885ATM 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.